PatientsLikeMe : Solifenacin Treatment Report

See More Treatments

See all treatments in the PatientsLikeMe system shared by patients just like you.

Taking Solifenacin
70 Patients currently take Solifenacin
14 Patients stopped taking Solifenacin
dulcijean Sensation: Moderate Overall: Mild Cognition: moderate Vision: mild Speech: none Swallowing: moderate Upper limb: moderate Walking: moderate See profile dulcijean Vesicare, mg since May 09, 2006
gecc4 Mouth/throat: mild Arms: moderate Chest: none Legs: moderate See profile gecc4 Vesicare, 20mg daily since Jul 26, 2007
candaceschultz Sensation: Moderate Overall: Mild Cognition: moderate Vision: moderate Speech: moderate Swallowing: mild Upper limb: none Walking: moderate See profile candaceschultz 5mg daily since May 01, 2008

What is Solifenacin? Solifenacin is an anticholinergic medication used to treat overactive bladder. It works by relaxing the bladder muscles to prevent urgent, frequent, or uncontrolled urination. It comes as a tablet taken by mouth, usually once a day, with or without food. Read more...

See more information, including instructions, precautions, side effects, and interactions.

Jump to:: Reasons Taken; Dosages; Duration; Patient Evaluations

Reasons Taken

84 patients in the community are taking or have taken Solifenacin.

Reason	# Patients	Percentage of patients
Bladder problems	59	70%
Other	17	20%
General health	3	3%
Urinary urgency	2	2%
urinary problems	1	1%

Dosages

Based on the patients currently taking Solifenacin.

0 mg day	0.5 mg day	5 mg day	10 mg day	15 mg day	20 mg day	50 mg day
4	1	26	24	1	5	1

Duration

How long current patients have been taking Solifenacin or how long patients were taking Solifenacin before stopping.

Currently taking Solifenacin

0-1 month	1-3 months	3-6 months	6 months-1year	1-2 years	2 years or more
1	3	3	12	16	11

Stopped taking Solifenacin

0-1 month	1-3 months	3-6 months	6 months-1year	1-2 years	2 years or more
1	3	3	4	1	2

Why Patients Stopped Taking Solifenacin (multiple reasons could be selected)
Reason	# Patients	Percentage of patients
Did not seem to work	5	36%
Side effects too severe	3	21%
Other	3	21%
Expense	2	14%
Doctor's advice	2	14%

Patient Reported Evaluations

Results from 6 patient evaluations. See the overall results and all individual evaluations.

Efficacy (Effect based on reason taken)

Major	33%	2
Moderate	33%	2
Slight	33%	2

Bladder problems

Side-effects (as an overall problem)

Severe	0%	0
Moderate	0%	0
Mild	33%	2
None	67%	4

Top reported side-effects include: dry mouth

Summary results are based on 6 individual responses. For more information, see overall results for Adherence, Burden and Cost.

Individual Patient Reported Evaluations (1 of 6)

thjuland

Sensation: Mild

Overall: Mild

Cognition: moderate

Vision: moderate

Speech: mild

Swallowing: none

Upper limb: moderate

Walking: moderate

See profile
by thjuland
Sep 21, 2008